Search - tctmd.com

Displaying 61 - 80 of 92

Sort: Relevancy | Date

Presentation ESC 2017

Undertreatment of Female Patients in Lipid-Lowering for Secondary Prevention in Europe, Canada, South Africa, Middle East and China

Presenter: Anselm K. Gitt

August 30, 2017

Presentation ESC 2017

Clinical Efficacy and Safety of Achieving Very Low LDL-C Levels With the PCSK9 Inhibitor Evolocumab in the FOURIER Outcomes Trial

Presenter: Robert Giugliano

August 28, 2017

Presentation SCCT 2017

Calcium Progression and Warranty Periods: A Role for Repeat Scanning

Presenter: Matthew Budoff

July 13, 2017

Presentation ACC 2017

Results of the CARAT Study: Effect of Serial Infusions of CER-001, a Pre-Beta High-Density Lipoprotein Mimetic on Coronary Atherosclerosis

Presenter: Stephen J Nicholls

March 20, 2017

Presentation ACC 2017

EBBINGHAUS: A Cognitive Study of Patients Enrolled in the FOURIER Trial

Presenter: Robert Giugliano

March 19, 2017

Presentation ACC 2017

ORION-1: Primary Efficacy & Safety Outcomes

Presenter: Kausik K. Ray

March 17, 2017

Presentation TCT 2016

COLOR: A Prospective, Multicenter Registry Evaluating the Relationship Between Lipid-Rich Plaque and Two-Year Outcomes After Stent Implantation in Patients With Coronary Artery Disease

Presenter: Howard C. Herrmann, Robert J. de Winter, Giora Weisz

November 01, 2016

Presentation TCT 2016

Hot Topic #2: Lipid Lowering Targets and the Potential Role of the PSCK9 Inhibitors in Routine Clinical Practice

Presenter: Bernard J. Gersh, Felix Mahfoud, Evan A. Stein

November 01, 2016

Presentation

Reduction in Total CV Events With Ezetimibe-Simvastatin Post-ACS: IMPROVE-IT

Presenter: SA. Murphy

January 25, 2016

Presentation

Negative Statin-Related News Stories Decrease Statin Persistence and Increase MI-CV Mortality

Presenter: Sune Nielsen

December 01, 2015

Presentation

Availability and Affordability of Cardiovascular Disease Medicines and Their Effect on Use in High-, Middle-, and Low-Income Countries

Presenter: R. Khatib

October 26, 2015

Presentation

Impact of Dual Lipid Lowering With Ezetimibe and Atorvastatin on Plaque Regression in PCI Patients

Presenter: K. Tsujita

July 28, 2015

Presentation SCCT 2015

Identifying Risk Beyond Stenosis in the ED Lessons Learned from ROMICAT

Presenter: Maros Ferencik

July 18, 2015

Presentation

Atheroma Progression in Hyporesponders to Statin Therapy

Presenter: Y. Kataoka

March 11, 2015

Presentation

Early High-Dose Rosuvastatin and Cardioprotection

Presenter: M. Leoncini

August 19, 2014

Presentation

Preprocedural Statin Use in PCI Patients

Presenter: M. Kenaan

April 21, 2014

Presentation

Meta-analysis of Time-Related Benefits of Statin Therapy in Patients with ACS Undergoing PCI

Presenter: Eliano Pio Navarese

March 10, 2014

Presentation

Preoperative Statins and Limb Salvage after Lower Extremity Revascularization in the Medicare Population

Presenter: Todd R. Vogel

December 11, 2013

Presentation

High-Dose Atorvastatin on the Pharmacodynamic Effects of Double-Dose Clopidogrel in Patients Undergoing PCI

Presenter: 147520|Massimo Leoncini

February 24, 2013

Presentation TCT 2013

Release of Bioactive Lipids During Percutaneous Coronary, and Peripheral Arterial Interventions in Humans: Lipidomic analysis of Distal Embolic Protection Devices.

Presenter: Amir Ravandi, Gregor Leibundgut, Patrick Hu, Anand Prasad, Brian Kolski, Bahram Khadivi, Mitul Patel, Ehtisham Mahmud, Yury Miller, Edward Dennis, Joseph Witztum, Sotirios Tsimikas

January 31, 2013

Advertisement

Undertreatment of Female Patients in Lipid-Lowering for Secondary Prevention in Europe, Canada, South Africa, Middle East and China

Clinical Efficacy and Safety of Achieving Very Low LDL-C Levels With the PCSK9 Inhibitor Evolocumab in the FOURIER Outcomes Trial

Calcium Progression and Warranty Periods: A Role for Repeat Scanning

Results of the CARAT Study: Effect of Serial Infusions of CER-001, a Pre-Beta High-Density Lipoprotein Mimetic on Coronary Atherosclerosis

EBBINGHAUS: A Cognitive Study of Patients Enrolled in the FOURIER Trial

ORION-1: Primary Efficacy & Safety Outcomes

COLOR: A Prospective, Multicenter Registry Evaluating the Relationship Between Lipid-Rich Plaque and Two-Year Outcomes After Stent Implantation in Patients With Coronary Artery Disease

Hot Topic #2: Lipid Lowering Targets and the Potential Role of the PSCK9 Inhibitors in Routine Clinical Practice

Reduction in Total CV Events With Ezetimibe-Simvastatin Post-ACS: IMPROVE-IT

Negative Statin-Related News Stories Decrease Statin Persistence and Increase MI-CV Mortality

Availability and Affordability of Cardiovascular Disease Medicines and Their Effect on Use in High-, Middle-, and Low-Income Countries

Impact of Dual Lipid Lowering With Ezetimibe and Atorvastatin on Plaque Regression in PCI Patients

Identifying Risk Beyond Stenosis in the ED Lessons Learned from ROMICAT

Atheroma Progression in Hyporesponders to Statin Therapy

Early High-Dose Rosuvastatin and Cardioprotection

Preprocedural Statin Use in PCI Patients

Meta-analysis of Time-Related Benefits of Statin Therapy in Patients with ACS Undergoing PCI

Preoperative Statins and Limb Salvage after Lower Extremity Revascularization in the Medicare Population

High-Dose Atorvastatin on the Pharmacodynamic Effects of Double-Dose Clopidogrel in Patients Undergoing PCI

Release of Bioactive Lipids During Percutaneous Coronary, and Peripheral Arterial Interventions in Humans: Lipidomic analysis of Distal Embolic Protection Devices.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content